9781789239478 - Hepatitis B and C (Infectious Diseases, 5) (12 resultados)

Condición: New.

Condición: New.

Condición: As New. Unread book in perfect condition.

Condición: New.

Condición: As New. Unread book in perfect condition.

HRD. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Gebunden. Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. KlappentextrnrnThis book on Hepatitis B and C contains very useful and recent information about the general characteristics of these common types of chronic liver infections. Referred to as Hepatitis B, there are three chapters describing the ma.

Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book on Hepatitis B and C contains very useful and recent information about the general characteristics of these common types of chronic liver infections. Referred to as Hepatitis B, there are three chapters describing the main epidemiological, clinical, therapeutic, and prognosis aspects. The molecular variants for HBsAg, its genotyping, and their clinical implications are fully analyzed. The implications of coinfection Hepatitis B and C in HIV patients and their treatment are described. In relation to Hepatitis C, there are three chapters describing the general characteristics of this chronic viral infection. The challenges and strategies for access to treatment of Hepatitis C in Latin America are fully covered and these can be applied in other countries with similar epidemiological and financial problems for access to treatment on a large scale. The role of direct-acting antivirals (DAA) in the treatment of chronic Hepatitis C infection with liver cirrhosis is clearly documented. 112 pp. Englisch.

Condición: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.

Buch. Condición: Neu. Hepatitis B and C | Luis Rodrigo (u. a.) | Buch | Gebunden | Englisch | 2020 | IntechOpen | EAN 9781789239478 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand.

Buch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book on Hepatitis B and C contains very useful and recent information about the general characteristics of these common types of chronic liver infections. Referred to as Hepatitis B, there are three chapters describing the main epidemiological, clinical, therapeutic, and prognosis aspects. The molecular variants for HBsAg, its genotyping, and their clinical implications are fully analyzed. The implications of coinfection Hepatitis B and C in HIV patients and their treatment are described. In relation to Hepatitis C, there are three chapters describing the general characteristics of this chronic viral infection. The challenges and strategies for access to treatment of Hepatitis C in Latin America are fully covered and these can be applied in other countries with similar epidemiological and financial problems for access to treatment on a large scale. The role of direct-acting antivirals (DAA) in the treatment of chronic Hepatitis C infection with liver cirrhosis is clearly documented.Books on Demand GmbH, Überseering 33, 22297 Hamburg 112 pp. Englisch.

Buch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This book on Hepatitis B and C contains very useful and recent information about the general characteristics of these common types of chronic liver infections. Referred to as Hepatitis B, there are three chapters describing the main epidemiological, clinical, therapeutic, and prognosis aspects. The molecular variants for HBsAg, its genotyping, and their clinical implications are fully analyzed. The implications of coinfection Hepatitis B and C in HIV patients and their treatment are described. In relation to Hepatitis C, there are three chapters describing the general characteristics of this chronic viral infection. The challenges and strategies for access to treatment of Hepatitis C in Latin America are fully covered and these can be applied in other countries with similar epidemiological and financial problems for access to treatment on a large scale. The role of direct-acting antivirals (DAA) in the treatment of chronic Hepatitis C infection with liver cirrhosis is clearly documented.